Bedel, Gary W.
Uppsala University · University of Hull · Hadassah Medical Center · Translational Research Institute for Metabolism and Diabetes · AdventHealth · University of Nebraska Medical Center · Hull York Medical School · University of Sheffield
2 papers on CoChat
Most cited papers
- Verified
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
le Roux, C. W., Astrup, A., Fujioka, K., Greenway, F., Lau, D. C. W., Van Gaal, L., Ortiz, R. V., Wilding, J. P. H., Skjøth, T. V., Manning, L. S., et al. (2017) · The Lancet
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 850
- Verified
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
Mosenzon, O., Blicher, T. M., Rosenlund, S., Eriksson, J. W., Heller, S., Hels, O. H., Pratley, R., Sathyapalan, T., Desouza, C., Abramof, R., et al. (2019) · The Lancet Diabetes & Endocrinology
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 351
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free